Chair, Brandon BioCatalyst
| Role | Organisation | Sources |
|---|---|---|
| Chair (former) | Brandon BioCatalyst | Brandon BioCatalyst (19 Aug 2025), Brandon BioCatalyst (22 May 2023), Brandon Capital |
Stories naming Bill Ferris AC. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Brandon BioCatalyst has named Peter Beattie its chair as Bill Ferris retires, with Andrew Nash joining the board and Ross King becoming deputy; manager Brandon Capital's newly raised $439 million fund was noted.
Sydney cancer-therapy developer AdvanCell has completed a US$112 million Series C that was oversubscribed, co-led by four investors, with Brandon Capital among new backers; three investor representatives join the board.
Cardiac pacing company EBR Systems says its SOLVE-CRT trial hit its safety and efficacy goals early, keeping a 2024 US approval bid on course; the article also recalls its 2021 ASX listing.